KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Non-cash Items (2019 - 2025)

Historic Non-cash Items for Globus Medical (GMED) over the last 7 years, with Q3 2025 value amounting to $7.4 million.

  • Globus Medical's Non-cash Items rose 74.67% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 million, marking a year-over-year increase of 74.67%. This contributed to the annual value of $298.6 million for FY2024, which is 38561.04% up from last year.
  • According to the latest figures from Q3 2025, Globus Medical's Non-cash Items is $7.4 million, which was up 74.67% from $66.3 million recorded in Q2 2025.
  • In the past 5 years, Globus Medical's Non-cash Items registered a high of $320.0 million during Q2 2021, and its lowest value of $4.4 million during Q3 2021.
  • Over the past 5 years, Globus Medical's median Non-cash Items value was $61.5 million (recorded in 2023), while the average stood at $94.0 million.
  • In the last 5 years, Globus Medical's Non-cash Items soared by 496928.29% in 2021 and then plummeted by 9760.38% in 2022.
  • Quarter analysis of 5 years shows Globus Medical's Non-cash Items stood at $231.9 million in 2021, then crashed by 97.6% to $5.6 million in 2022, then surged by 1006.71% to $61.5 million in 2023, then soared by 385.61% to $298.6 million in 2024, then plummeted by 97.51% to $7.4 million in 2025.
  • Its last three reported values are $7.4 million in Q3 2025, $66.3 million for Q2 2025, and $7.0 million during Q1 2025.